(422 days)
Air Next is intended to be used by:
Healthcare professionals trained to perform spirometry tests on patients of age ≥ 5 years old, > 10 kg and > 110 cm.
Air Next is intended to perform basic lung function and spirometry testing. The actual diagnosis shall be done by a healthcare professional in hospital and clinical settings.
Air Next is intended to perform basic lung function and spirometry testing. It measures parameters such as the forced expiratory volume in 1 sec (FEV1) and the forced vital capacity (FVC) in a forced expiratory maneuver. These measures can be used for detection, assessment and monitoring of diseases affecting the lung function, such as bronchial Asthma, COPD and Cystic Fibrosis.
Air Next is a hand-held spirometer, weighing only 75g and it is powered by 2 AAA alkaline 1.5V batteries. lt consists of 3 main components: the Air Next device, the NuvoAir disposable turbine (delivered in one package) and the Air Next mobile application downloadable from Apple's and Google's Play Stores. The package includes one Air Next device, one NuvoAir disposable turbine through which the user can start using the Air Next, two AAA 1.5V alkaline batteries, one user manual and one cotton bag to carry the device. Dimensions of the Air Next are 98 x 62 x 26 mm, which can be seen in the engineering drawing in the attachments.
Here's an analysis of the provided text regarding the acceptance criteria and supporting studies for the Air Next spirometer, structured according to your request:
1. Table of Acceptance Criteria and Reported Device Performance
The document states that the Air Next spirometer meets ATS/ERS 2005 guidelines and ISO standards for spirometers. The performance of the Air Next related to specific technical specifications is compared directly to the predicate device, implying these represent the acceptance criteria derived from industry standards.
| Feature / Acceptance Criteria (per ATS/ERS 2005, ISO standards, and predicate comparison) | Reported Device Performance (Air Next) |
|---|---|
| Volume Accuracy | ±3% of reading or ±0.050 L, whichever is greater (Same as predicate) |
| Volume Range | Up to 10 L (Same as predicate) |
| Flow Range | 0-15 L/s (Similar to predicate's 0-16 L/s) |
| Flow Accuracy | ±5% or 200 mL/s (Same as predicate) |
| Flow Resistance | <0.5 cmH2O/L/s (Same as predicate) |
| Electrical Safety (IEC 60601-1) | Pass |
| Electromagnetic Compatibility (IEC 60601-1-2) | Pass |
| Usability (IEC 60601-1-6, IEC 62366) | Pass |
| Biocompatibility (ISO 10993-1, -5, -10) | Pass for Cytotoxicity, Irritation/Intracutaneous Reactivity, Irritation and Sensitization (for handle/exterior and disposable turbine through predicate equivalency) |
| ATS Accuracy Requirements | Yes |
| Performance against ATS guidelines & BTPS conditions | Results "well within range" |
2. Sample Size Used for the Test Set and Data Provenance
The document does not explicitly state a sample size for the test set for the spirometry performance characteristics (volume, flow accuracy, etc.). The performance testing described primarily refers to adherence to international standards and direct comparison of specifications with a predicate device.
The data provenance is not specified in terms of country of origin or whether it was retrospective or prospective. The testing appears to be primarily lab-based performance verification against established standards rather than clinical data from human subjects.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications
This information is not provided in the document. The ground truth for the device's technical performance metrics (volume, flow accuracy, etc.) is established by recognized international standards (ATS/ERS 2005, ISO 26782, ISO 23747) and likely verified using calibrated testing equipment. There's no mention of human experts defining ground truth for these quantitative measurements.
4. Adjudication Method for the Test Set
Adjudication methods (e.g., 2+1, 3+1) are typically used in studies involving human interpretation or subjective assessments. Since the performance testing focuses on objective technical measurements verified against standards, an adjudication method for a "test set" in this context is not applicable and not mentioned.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
No, a Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not done or reported. The device is a diagnostic spirometer for basic lung function testing, not an AI-assisted diagnostic imaging device that would typically involve MRMC studies to assess human reader improvement with AI.
6. Standalone Performance Study
Yes, a standalone performance assessment was conducted. The "Performance Testing" section describes various tests against international standards (IEC 60601-1, IEC 60601-1-6, IEC 62366, IEC 60601-1-2) and the ATS/ERS 2005 guidelines. It also explicitly states that the device was tested against B.T.P.S. conditions and that "results are well within range."
The technical specifications for volume and flow accuracy are presented as direct measurements or capabilities of the device itself. While there is a comparison to a predicate device, the Air Next's own performance against these metrics constitutes standalone testing.
7. Type of Ground Truth Used
The ground truth used for the device's performance is based on established international standards and guidelines for spirometry. Specifically, the ATS/ERS 2005 guideline, EN ISO 26782:2009 (Anesthetic and respiratory equipment – Spirometers), and EN ISO 23747:2015 (Peak expiratory flowmeters) are cited. These standards define the acceptable ranges and methodologies for measuring spirometry parameters accurately.
8. Sample Size for the Training Set
This document does not describe any machine learning or AI components that would require a "training set". The Air Next is a hardware device with firmware that converts rotations into airflow measurements. Therefore, a training set sample size is not applicable in the context described.
9. How the Ground Truth for the Training Set Was Established
As there is no mention of a training set for machine learning/AI, the method for establishing its ground truth is not applicable. The device's functionality relies on physical principles and standard conversion algorithms, not learning from data.
{0}------------------------------------------------
January 2, 2020
Image /page/0/Picture/1 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
NuvoAir AB % Yolanda Smith Consultant Smith Associates 1468 Harwell Ave Crofton, Maryland 21114
Re: K183089
Trade/Device Name: Air Next Regulation Number: 21 CFR 868.1840 Regulation Name: Diagnostic Spirometer Regulatory Class: Class II Product Code: BZG Dated: December 20, 2019 Received: December 30, 2019
Dear Yolanda Smith:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
{1}------------------------------------------------
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
for Michael Rvan Division Director DHT1C: Division of ENT, Sleep Disordered Breathing, Respiratory and Anesthesia Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K183089
Device Name Air Next
Indications for Use (Describe)
Air Next is intended to be used by:
Healthcare professionals trained to perform spirometry tests on patients of age ≥ 5 years old, > 10 kg and > 110 cm.
Air Next is intended to perform basic lung function and spirometry testing. The actual diagnosis shall be done by a healthcare professional in hospital and clinical settings.
Type of Use (Select one or both, as applicable)
| ☑ Prescription Use (Part 21 CFR 801 Subpart D) |
|---|
| ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
510(k) Summary
SPONSOR
| Company Name:Company Address | NuvoAir AB17 RiddargatanStockholm 114 57Sweden |
|---|---|
| Telephone: | +46 725538233 |
| Contact Person: | Vanessa Caldeira |
Summary Preparation Date: December 31, 2019
DEVICE NAME
| Trade Name: | Air Next |
|---|---|
| Common/Usual Name: | Spirometer |
| Classification Name: | Diagnostic Spirometer |
| Regulation Number: | 21 CFR 868.1840 |
| Product Code: | BZG |
| Device Class: | Class II |
| Reviewing Panel: | Anesthesiology |
PREDICATE DEVICE
Legally Marketed Equivalent Device
| Predicate | K Number | Brand Name | Company |
|---|---|---|---|
| Primary | K072979 | Spirobank G | MIR Medical International Research |
| Reference | K061712 | Spirobank II | MIR Medical International Research |
DEVICE DESCRIPTION
Air Next is intended to perform basic lung function and spirometry testing. It measures parameters such as the forced expiratory volume in 1 sec (FEV1) and the forced vital capacity (FVC) in a forced expiratory maneuver. These measures can be used for detection, assessment and monitoring of diseases affecting the lung function, such as bronchial Asthma, COPD and Cystic Fibrosis.
Air Next is a hand-held spirometer, weighing only 75g and it is powered by 2 AAA alkaline 1.5V batteries. lt consists of 3 main components: the Air Next device, the NuvoAir disposable turbine (delivered in one package) and the Air Next mobile application downloadable from Apple's and Google's Play Stores. The package includes one Air Next device, one NuvoAir disposable turbine through which the user can start using the Air Next, two AAA 1.5V alkaline batteries, one user manual and one cotton bag to carry the device. Dimensions of the Air Next are 98 x 62 x 26 mm, which can be seen in the engineering drawing in the attachments.
DEVICE INDICATIONS FOR USE
Air Next is intended to be used by:
Healthcare professionals trained to perform spirometry tests on patients of age ≥ 5 years old, > 10 kg and ≥ 110 cm.
Air Next is intended to perform basic lung function and spirometry testing. The actual diagnosis shall be done by a healthcare professional in hospital and clinical settings.
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a dentist or physician.
{4}------------------------------------------------
COMPARISON OF TECHNICAL CHARACTERISTICS
Predicate Product Comparison Table
| Feature | Subject Device | Primary PredicateK072979 | Similarities andDifferences |
|---|---|---|---|
| Manufacturer | NuvoAir | M.I.R. MedicalInternational Research | Same |
| Product Code | BZG | BZG | Same |
| Regulation No, | 21 CFR 868.1840 | 21 CFR 868.1840 | Same |
| Indications forUse | Air Next is intended to beused by:Healthcare professionalstrained to perform spirometrytests on patients of age$\ge$ 5 years old, > 10 kgand $\ge$ 110 cm.Air Next is intended toperform basic lung functionand spirometry testing.The actual diagnosis shall bedone by a healthcareprofessional in hospital andclinical settings. | The Spirobank Gspirometer is intended tobe used by a physician orby a patient under theinstruction of a physicianor paramedic. The deviceis intended to test lungfunction and can makespirometry testing inpeople of all ages,excluding infants andneonates. It can be usedin any setting. | Similarindications forthe use. The onlydifferencebetween subjectdevice andpredicate deviceis that theIndications forUse in the subjectdevice includesalso weight andheight whilePredicate deviceonly uses age as alimitation. Subjectdevice is not foruse in homesetting. |
| UseEnvironment | Hospital and clinicalsettings. | All settings thatinclude clinical andhome use | DifferentUse is limited toclinical settingsonly. |
| Intended User | Trained health careprofessionals performspirometry testing onAdults and pediatric patientsover 5 years old | People of all ages,excluding infants andneonates. | Different |
| Prescriptiononly | Yes | Yes | Same |
| Feature | Subject Device | Primary Predicate K072979 | Similarities and Differences |
| Principle of Operation | The Air Next is designed to work with NuvoAir disposable turbine. When performing a spirometry test, the user exhales into the turbine. The airflow generated is forcing a propeller to rotate inside the turbine. The Air Next registers the speed of the spinning propeller by counting the rotations with a digital infrared interruption sensor. The algorithm in the firmware inside the Air Next device then converts the rotations into airflow measured in liters per second.The device is also tested against B.T.P.S. (body temperature and pressure with saturated water vapor) conditions as prescribed by ATS guidelines and the results are well within range. | Spirobank G is a powerful and compact measurement device, intended for use by a respiratory specialist or by a suitably trained generalist.Two different types of turbine sensors can be used with the device, one is reusable and one is single-patient disposable. A disposable mouthpiece is required in order to connect a subject to the spirometer.The flow and volume measurement sensor is a digital turbine, based on the infrared interruption principle.Cleaning of the disposable turbine is not required, as it is supplied clean in a sealed plastic bag. It must be disposed of after use.Spirometry test interpretation is based on the Forced Vital Capacity (FVC) test and is based on the ATS standard. | Same |
| Flow Sensor | Bidirectional turbine with infrared interruption | Bidirectional turbine with infrared | Same |
| Physical Characteristics | |||
| Energy Type | Two AAA 1.5V Alkaline batteries | 9V Alkaline battery | Different |
| Display | Touchscreen on smartphone or tablet | Touchscreen / LCD and membrane | Different |
| Operating Environment | T: min +10°C/max +40° CRH: min 10 %/max 95 % ALT: max 2000 m | Temperature: MIN + 10 °C, MAX + 40 °C;Humidity: MIN 10% RH; MAX 95%RH | Same |
| Physical Size | Light hand-held device | Light hand-held device | Same |
| Feature | Subject Device | Primary PredicateK072979 | Similarities andDifferences |
| Weight | 75g | 160g | Different |
| Technical Specifications | |||
| Volumeaccuracy | ±3% of reading or±0.050 L, whichever is greater | ±3% of reading or±0.050 L, whichever isgreater | Same |
| Volume range | Up to 10 L | Up to 10 L | Same |
| Flow range | 0-15/s | 0-16 L/s | Similar |
| Flow accuracy | ±5% or 200 mL/s | ±5% or 200 mL/s | Same |
| Flow resistance | <0.5 cmH2O/L/s | <0.5 cmH2O/L/s | Same |
| Connectivity | Bluetooth | Bluetooth of USB | Same -Bluetooth |
| Measured parameter | |||
| Forced vitalcapacity | FVC | FVC | Same |
| Volume expiredin the first | FEV0.75, FEV1, FEV3, FEV6 | FEV0.75, FEV1, FEV3, FEV6 | Same |
| Ratio betweenvolume expiredin a certaintime periodand FVC | FEV/FVC (FER) for 0.75 /1/3 / 6 | FEV/FVC (FER) for 0.75/1 /3 / 6 | Same |
| Peak expiratoryflow | PEF | PEF | Same |
| Forcedexpiratory flowbetween thefirst 25% and75% of the FVC | FEF25-75 (MEF) | FEF25-75 (MEF) | Same |
| Volumeinspired in thefirst second ofthe test | FIV1 | FIV1 | Same |
| Forcedinspiratoryvolume | FIVC | FIVC | Same |
| Peak inspiratoryflow | PIF | PIF | Same |
| Feature | Subject Device | Primary PredicateK072979 | Similarities andDifferences |
| Forcedinspiratory flowin the first 25%and 75% of theFIV | FIF25-75 (MIF25-75) | FIF25-75 (MIF25-75) | Same |
| Ratio betweenFEV1 and FEV6 | FEV1/FEV6 | FEV1/FEV6 | Same |
| Forcedexpiratory flowat 50% of FVCdivided by FVC | FEF50/FVC | FEF50/FVC | Same |
| Forcedinspiratory flowin the first 25%and 75% of theFIV | FIF25-75 (MIF25-75) | FIF25-75 (MIF25-75) | Same |
| Ratio betweenFEV1 and FEV6 | FEV1/FEV6 | FEV1/FEV6 | Same |
| Forcedexpiratory flowat 50% of FVCdivided by FVC | FEF50/FVC | FEF50/FVC | Same |
| Forceinspiratory flowat first seconddevice forcedinspiratoryvolume | FIV1/FIVC (FIR) | FIV1/FIVC (FIR) | Same |
| Forcedexpiratory time | FET | FET | Same |
| Maximumvoluntaryventilation | N/A | MVV (ind) | Different |
| Device Use Design | |||
| Used with PFTfilter and / ormouthpiece | Mouthpiece Disposable | Mouthpiece Disposable orReusable | Same for DisposableTurbine – Seereference predicatechart below |
| Coaching | Display of flow-time curves,timer and effort during test | Display of volume-time andflow-volume curves | Different |
| Feedback ontest quality | Yes - according to ATSguidelines | Yes – Traffic lights forinterpretation | Similar |
| Graphic display | Yes- on App | Yes on device screen | Different |
| Safety Standards | |||
| Feature | Subject Device | Primary PredicateK072979 | Similarities andDifferences |
| AppliedStandards forsafety | Electrical Safety StandardIEC 60601-1Electro Magnetic CompatibilityIEC 60601-1-2 | Electrical Safety StandardIEC 60601-1Electro MagneticCompatibilityIEC 60601-1-2 | Same |
| AppliedStandards forsafety | Electrical Safety StandardIEC 60601-1Electro Magnetic CompatibilityIEC 60601-1-2 | Electrical Safety StandardIEC 60601-1Electro MagneticCompatibilityIEC 60601-1-2 | Same |
| Biocompatibility | According to ISO 10993-1 | According to ISO 10993-1 | Same |
| Meets ATSaccuracyrequirements | Yes | Yes | Same |
{5}------------------------------------------------
{6}------------------------------------------------
{7}------------------------------------------------
{8}------------------------------------------------
Reference Device
The disposable turbine used in Air Next device is manufactured and purchased from MIR Medical International Research and is cleared under K061712. The disposable turbine is supplied in its final finished form and is identical to the reference predicate device.
PERFORMANCE TESTING
The following performance data were provided in support of the substantial equivalence determination.
Safety testing
| Testing Standard | Test Description | Result |
|---|---|---|
| IEC 60601-1:2005 (Third Edition)+ CORR. 1:2006 + CORR. 2:2007 +A1:2012 | Medical electrical equipment - Part 1: generalrequirements for basic safety and essentialperformance | Pass |
| IEC 60601-1-6:2010, AMD1:2013 | Medical electrical equipment - Part 1-6: Generalrequirements for basic safety and essentialperformance - Collateral standard: Usability | Pass |
| IEC 62366:2007 | Medical devices – Application of usability engineeringto medical devices | Pass |
| IEC · 60601-1-2:2014 (ED. 4) | Medical electrical equipment - Part 1-2: Generalrequirements for basic safety and essentialperformance - Collateral Standard: Electromagneticdisturbances - Requirements and tests | Pass |
Biocompatibility
Handle and Exterior Surface
The Handle and Exterior is designed to be a surface device for intact skin with limited contact A – limited (≤24 h). The following testing was performed:
{9}------------------------------------------------
Based on the device categorization outlined above, the material contact and the guidance given in ISO 10993-1, the tests deemed appropriate for the device materials were selected as shown in the table below.
| Biological Effect | Test | ComplianceStandard |
|---|---|---|
| Cytotoxicity | Mem Elution | ISO10993-5 |
| Irritation or IntracutaneousReactivity | Intracutaneous Injection Test | ISO10993-10 |
| Irritation and Sensitization | Kligman Maximization test | ISO10993-10 |
Disposable Turbine
NuvoAir Turbines are disposable turbines intended for single use for a period of less than 24hr. NuvoAir has provided a declaration statement from the legal manufacturer, MIR, stating that the NuvoAir disposable turbine for Air Next Spirometer (ref. code 910007) is identical in its final finished form to the disposable turbine legally marketed and identified with code 910004 and that this turbine is in turn legally US-marketed Spirobank II (K061712).
Additional Testing Standards
- ATS/ERS 2005 guideline ●
- ISO 14971:2007 - Application of risk management to medical devices.
- IEC 62366:2007 + A1:2014. Application of usability engineering to medical devices.
- ISO 62304:2006/A1:2015: Medical device software. Software life-cycle processes
- EN ISO 26782: 2009, Anesthetic and respiratory equipment – Spirometers intended for the measurement of time forced expired volumes in humans
- . EN ISO 23747:2015, Anesthesia and respiratory equipment - Peak expiratory flowmeters for the assessment of pulmonary function in spontaneously breathing humans
- . FCC Part 15, Subpart B, C
Clinical testing was not performed with this device.
Substantial Equivalence Conclusion:
Based upon the foregoing performance testing and comparison to the legally marketed predicate devices for indications for use, technology, and performance we believe we have demonstrated that the Air Next is substantially equivalent and as effective as the predicate device. Furthermore, the differences versus the predicate device do not impact safety and effectiveness.
§ 868.1840 Diagnostic spirometer.
(a)
Identification. A diagnostic spirometer is a device used in pulmonary function testing to measure the volume of gas moving in or out of a patient's lungs.(b)
Classification. Class II (performance standards).